Hostname: page-component-78c5997874-mlc7c Total loading time: 0 Render date: 2024-11-16T15:37:20.627Z Has data issue: false hasContentIssue false

EPA-0499 – Hysterical Psychosis

Published online by Cambridge University Press:  15 April 2020

R. Melo
Affiliation:
Psychiatry, Hospital Divino Espírito Santo, Ponta Delgada, Portugal
JC. Alves
Affiliation:
Psychiatry, Hospital Divino Espírito Santo, Ponta Delgada, Portugal

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Introduction:

The term hysterical psychosis has been in common usage for longer than half a century, but has never become part of the standard nomenclature. This entity is characterized by acute onset, often following the occurrence of an emotionally disturbing event, absence of any characteristic thought disturbance, and affectivity changes in the direction of volatility. Its manifestations can also include hallucinations, delusions, depersonalization and behavior disorders. Though the acute episode seldom lasts from one to three weeks, it has good prognosis and there is practically no residue after the symptoms disappear.

Aims:

A review about the evolution and the actual interest and adequacy of this clinical entity. The very existence of hysterical psychosis as a diagnostic entity has been questioned as part of the general difficulty in defining both hysteria and psychosis.

Methods:

A non-systematic review of PubMed articles.

Conclusion:

The hysterical psychosis occurs in patients with a hysterical personality / histrionic, with more colorful psychotic symptoms, which are somehow characteristic. This seems to condition the definition of a well defined nosological entity, as long as diagnostic, prognostic and therapeutic implications. It still seems questionable whether the concept of hysterical psychosis should be kept as an entity with well-defined etiologic determinants, however in clinical terms this approach may have advantages.

Type
P02 - Anxiety Disorders and Somatoform Disorders
Copyright
Copyright © European Psychiatric Association 2014
Submit a response

Comments

No Comments have been published for this article.